Rhythm Pharmaceuticals (RYTM) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$26.6 million.
- Rhythm Pharmaceuticals' Free Cash Flow fell 558.0% to -$26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.1 million, marking a year-over-year increase of 1228.54%. This contributed to the annual value of -$113.9 million for FY2024, which is 1639.09% up from last year.
- As of Q3 2025, Rhythm Pharmaceuticals' Free Cash Flow stood at -$26.6 million, which was down 558.0% from -$23.3 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Free Cash Flow ranged from a high of -$18.8 million in Q4 2024 and a low of -$53.8 million during Q1 2022
- In the last 5 years, Rhythm Pharmaceuticals' Free Cash Flow had a median value of -$34.0 million in 2022 and averaged -$34.8 million.
- Per our database at Business Quant, Rhythm Pharmaceuticals' Free Cash Flow tumbled by 6026.89% in 2022 and then surged by 3787.01% in 2023.
- Rhythm Pharmaceuticals' Free Cash Flow (Quarter) stood at -$40.5 million in 2021, then grew by 16.13% to -$34.0 million in 2022, then rose by 13.58% to -$29.4 million in 2023, then skyrocketed by 35.86% to -$18.8 million in 2024, then plummeted by 41.27% to -$26.6 million in 2025.
- Its Free Cash Flow stands at -$26.6 million for Q3 2025, versus -$23.3 million for Q2 2025 and -$40.4 million for Q1 2025.